Relationship of APOE gene polymorphism with subclasses of serum high density lipoprotein in hyperlipidemia

Chinese Journal of Medical Genetics

Volumn 21, Issue 6, 2004, Pages 615-618

  Long, Shi Yin ^a   Zhang, Xue Mei ^a   Fu, Ming De ^a   Xu, Yan Hua ^b   Liu, Bing Wen ^a  

^a SICHUAN UNIVERSITY   (China)

^b Hoist Group Postdoctoral Work Station   (China)

Author keywords

Apolipoprotein E; Genotype; High density lipoprotein subclasses; Hyperlipidemia; Polymerase chain reaction restriction fragment length polymorphism

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN;

ARTICLE; DNA POLYMORPHISM; GEL ELECTROPHORESIS; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; IMMUNODETECTION; LIPID BLOOD LEVEL; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 10644272748     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Xu YH, Fu MD, Liu BW, et al. Subclasses of serum HDL in hyperlipidemia. J Sichuan Univ (Med Sci Ed), 2003, 34: 238-241.
2. Asztalos BF, Schaefer EJ. High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol, 2003, 91 (7A): 12E-17E.
3. Asztalos BF, Roheim PS, Milani R, et al. Distribution of apoAI-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Bio, 2000, 20: 2670.
4. Luthra K, Bharghav B, Chabbra S, et al. Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem, 2002, 232: 97-102.
5. Ashavaid TF, Todur SP, Nair KG. Apolipoprotein E polymorphism and coronary heart disease. J Assoc Physicians India, 2003, 51: 784-788.
6. Zhang XM, Liu BW, Bai H, et al. Study on apoE gene polymorphism in Chinese endogenous hypertriglyceridemia. Chin J Med Genet, 2001, 18: 100-104.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972, 18: 499-502.
8. Wu XW, Fu MD, Liu BW, et al. The immunodetection method of high density lipoprotein subclasses in human serum. Chin J Arterioscler, 1999, 7: 253-255.
9. Larson IA, Ordovas JM, DeLuca C, et al. Association of apolipoprotein (apo) E genotype with plasma apoE levels. Atherosclerosis, 2000, 148: 327-335.
10. Xu YH, Fu MD. Alterations of HDL subclasses in hyperlipidemia. Clinica Chimica Acta, 2003, 332: 95-102.
11. Albers JJ, Pitman W, Wolfbause G, et al. Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains. J Lipid Res, 1999, 40: 295-301.
12. de Beer F, van Dijk KW, Jong MC, et al. Apolipoprotein E2 (Lys146 → Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-Triglycerides. Arterioscler Thromb Vasc Biol, 2000, 20: 1800-1806.
13. Dallongeville J, Lussier-Cacan S, Davignon J, et al. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res, 1992, 33: 447-454.
14. McGladderya SH, Frohlicha JJ. Lipoprotein lipase and apo E polymorphisms: relationship to hypertriglyceridemia during pregnancy. J Lipid Res, 2001, 42: 1905-1912.